Evidence map›Paper›PMID 40595313›Full record

ArticleScientific reports2025

Morin hydrate protects against cisplatin-induced testicular toxicity by modulating ferroptosis and steroidogenesis genes' expression and upregulating Nrf2/Heme oxygenase-1.

Yasmin Mahran, Amira M Badr, Sheka Aloyouni, Manal Mubarak Alkahtani, Wedad S Sarawi, Rehab Ali, Deema Alsultan, Sarah Almufadhili, Dalia H Almasud, Iman H Hasan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Protection byPharmaceuticals (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yasmin MahranResearch Department, Natural and Health Sciences Research Center, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
Amira M BadrDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia. amibadr@ksu.edu.sa.
Sheka AloyouniGenetics Section, Research Department, Natural and Health Sciences Research Center, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
Manal Mubarak AlkahtaniResearch Department, Natural and Health Sciences Research Center, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia.
Wedad S SarawiDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.
Rehab AliDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.
Deema AlsultanCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.
Sarah AlmufadhiliCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.
Dalia H AlmasudCollege of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.
Iman H HasanDepartment of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh, 11495, Saudi Arabia.

Funding

Princess Nourah bint Abdulrahman University Researchers Supporting Project PNURSP2025R3713
6 · The paper itself

Abstract

Cisplatin is a widely used, effective chemotherapy drug. However, its application is often limited by severe side effects, including testicular toxicity. Cisplatin-induced testicular damage is primarily driven by oxidative stress and inflammation. Ferroptosis has recently been identified to contribute to cisplatin-testicular toxicity. Morin hydrate (MH) is a naturally occurring flavonoid known for its powerful antioxidant, anti-inflammatory, and anti-apoptotic properties. The study was designed to evaluate the protective effects of MH against cisplatin-induced testicular toxicity in Wistar albino rats. Rats were given MH 50 mg/kg, p.o. daily for fourteen days, seven days before the injection of cisplatin 8 mg/kg. Assessment of sperm quality, testosterone, luteinizing hormone levels, and oxidative stress markers were carried out. Also, steroidogenesis and ferroptosis-related gene expressions were assessed. Results: Our findings demonstrated that MH significantly corrected the antioxidant/oxidant balance, evidenced by increased superoxide dismutase, glutathione peroxidase, and Nrf2/heme oxygenase-1 (HO-1) expression and reduced malondialdehyde in testicular tissue. Also, MH ameliorated the negative changes in sperm quality, hormone levels, and testicular histology induced by cisplatin, and this was accompanied by upregulation of steroidogenesis gene expressions (17β-HSD, 3β-HSD, and star). Moreover, MH inhibited cisplatin-induced ferroptosis via the modulation of ferroptosis genes' expression (ACSL4, SLC7A11, and TFRC) and the reduction of iron accumulation in testicular tissue. Conclusion: MH effectively protected against cisplatin-induced testicular toxicity by reducing oxidative stress and inhibiting ferroptosis signalling. This study points out that MH might mitigate iron-mediated apoptosis through the downregulation of Nrf2/HO-1 signaling, providing a potential therapeutic strategy for preventing infertility in male patients undergoing cisplatin chemotherapy.

Indexed as

CisplatinFerroptosisFlavonoidsHeme Oxygenase-1NF-E2-Related Factor 2TestisAnimalsAntioxidantsFlavonesGene Expression RegulationHeme Oxygenase (Decyclizing)MaleOxidative StressRatsRats, WistarTestosteroneAntioxidantsCisplatinFlavonesFlavonoidsHeme Oxygenase-1Heme Oxygenase (Decyclizing)Hmox1 protein, ratmorinNfe2l2 protein, ratNF-E2-Related Factor 2TestosteroneCisplatinFerroptosisMorin hydrateOxidative stressSteroidogenesisTesticular toxicity

Identifiers

PMID40595313
PMCPMC12217244

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.